PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA

Citation
Hr. Naik et al., PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA, International journal of oncology, 6(1), 1995, pp. 209-213
Citations number
23
Categorie Soggetti
Oncology
ISSN journal
10196439
Volume
6
Issue
1
Year of publication
1995
Pages
209 - 213
Database
ISI
SICI code
1019-6439(1995)6:1<209:PSOGIP>2.0.ZU;2-1
Abstract
Hormone refractory prostate cancer remains an incurable disease and th e discovery of newer agents with higher cytotoxic activity is required . Gossypol is a phenolic compound isolated from cottonseed oil which h as been shown to have anti-spermatogenic effects. In in vitro studies, gossypol appears to inhibit the growth of rat prostate cancer cell li ne MAT-LyLu and human prostate adenocarcinoma cell lines PC-3, LNCaP a nd DU-145. In vive, gossypol appeared to inhibit tumor growth of subcu taneously implanted MAT-LyLu cells in Copenhagen rats. Gossypol may be an active agent for the treatment of hormone refractory metastatic pr ostate cancer.